CHRISTINA MIYAKE to Treatment Outcome
This is a "connection" page, showing publications CHRISTINA MIYAKE has written about Treatment Outcome.
Connection Strength
0.413
-
Atrioventricular Nodal Ablation Is Not an Effective Treatment Strategy in Catecholaminergic Polymorphic Ventricular Tachycardia. Tex Heart Inst J. 2023 05 01; 50(3).
Score: 0.066
-
Trends in hospitalization and factors associated with in-hospital death among pediatric admissions with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2022 03; 33(3):502-509.
Score: 0.060
-
Early experience with intravenous sotalol in children with and without congenital heart disease. Heart Rhythm. 2018 12; 15(12):1862-1869.
Score: 0.047
-
Infant ventricular fibrillation after ST-segment changes and QRS widening: a new cause of sudden infant death? Circ Arrhythm Electrophysiol. 2013 Aug; 6(4):712-8.
Score: 0.033
-
Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate. Circ Arrhythm Electrophysiol. 2013 Jun; 6(3):579-87.
Score: 0.033
-
Dronedarone for the Treatment of Atrial Arrhythmias in Adults With Congenital Heart Disease. Tex Heart Inst J. 2024 04 30; 51(1).
Score: 0.018
-
Ripple mapping: A precise tool for atrioventricular nodal reentrant tachycardia ablation. J Cardiovasc Electrophysiol. 2022 06; 33(6):1183-1189.
Score: 0.015
-
Outcomes of Pediatric Patients With Defibrillators Following Initial Presentation With Sudden Cardiac Arrest. Circ Arrhythm Electrophysiol. 2021 02; 14(2):e008517.
Score: 0.014
-
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 12 22; 142(25):e558-e631.
Score: 0.014
-
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 12 22; 142(25):e533-e557.
Score: 0.014
-
Cardiac Arrest in Pediatric Patients Receiving Azithromycin. J Pediatr. 2017 03; 182:311-314.e1.
Score: 0.011
-
Percutaneous Pulmonary Valve Implantation-Associated Ventricular Tachycardia in Congenital Heart Disease. J Interv Cardiol. 2016 Dec; 29(6):639-645.
Score: 0.010
-
Reassessing Risk Factors in Pediatric Patients With Pacemakers Implanted for Atrioventricular Block: The Impact of Nonsustained Ventricular Tachycardia. J Cardiovasc Electrophysiol. 2016 Apr; 27(4):471-9.
Score: 0.010
-
Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. J Pediatr. 2015 Jan; 166(1):115-8.
Score: 0.009
-
Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database. Cardiol Young. 2015 Aug; 25(6):1080-5.
Score: 0.009
-
Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol. 2015 Jan; 36(1):146-50.
Score: 0.009
-
Management of pediatric tachyarrhythmias on mechanical support. Circ Arrhythm Electrophysiol. 2014 Aug; 7(4):658-63.
Score: 0.009
-
The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Europace. 2014 Feb; 16(2):277-83.
Score: 0.008
-
Incidence and risk factors of complete atrioventricular block after operative ventricular septal defect repair. Congenit Heart Dis. 2014 May-Jun; 9(3):211-5.
Score: 0.008
-
Insights into dyssynchrony in hypoplastic left heart syndrome. Heart Rhythm. 2012 Dec; 9(12):2010-5.
Score: 0.008
-
Predictors for use of temporary epicardial pacing wires after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2012 Sep; 144(3):557-62.
Score: 0.008